Streetbeat News

Earnings

LGVN

Longeveron (NASDAQ:LGVN) reported Q4 earnings with a per-share loss of $(0.25), missing the $(0.21) estimate, and sales of $63.00K, missing the $210.00K estimate. This represents a 19.05% increase in per-share losses and a 70% miss in sales estimates compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:35 pm

IPAR

Inter Parfums reported Q4 sales of $329.00 million, surpassing the analyst consensus estimate of $323.83 million by 1.60% and marking a 5.86% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:35 pm

RVLV

Revolve Group (RVLV) reported Q4 earnings with an EPS of $0.05, surpassing estimates by 150%. However, revenue decreased by $1.38 million compared to the same period last year. The company's past earnings performance shows mixed results, with a notable miss in Q3 2023 followed by a 1% drop in share price.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 9:35 pm

DVN

Devon Energy (NYSE:DVN) reported its Q4 earnings on February 27, 2024, with an EPS of $1.41, exactly meeting the estimated earnings but showing a revenue decrease of $154 million from the previous year. The company's past earnings performance indicates variability in meeting EPS estimates and revenue figures.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 9:35 pm

TMCI

Treace Medical Concepts (NASDAQ:TMCI) reported Q4 earnings with an EPS of $-0.1, missing estimates by -11.0%. Revenue increased by $12.44 million from the previous year. The company had previously experienced a 38.0% share price drop after missing EPS estimates last quarter.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 9:35 pm

LNW

Light & Wonder (NASDAQ:LNW) reported Q4 earnings with an EPS of $0.73, beating estimates by 9.0% and marking an $88.00 million revenue increase from the previous year. The company has shown a consistent pattern of surpassing EPS estimates, with a notable 11.0% share price increase following last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 9:35 pm

RYAN

Ryan Specialty Holdings (RYAN) reported Q4 earnings, beating estimates with an EPS of $0.35 against the expected $0.34. Revenue increased by $97.85 million from the previous year. The company has a history of surpassing earnings estimates, which previously led to a 2% share price increase the following day.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 9:35 pm

LNW

Light & Wonder (LNW) reported Q4 2023 earnings of $0.73 per share, surpassing the $0.67 estimate, with sales of $770M beating the $746.57M estimate, marking a 12.90% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:35 pm

TMCI

Treace Medical Concepts (TMCI) reported Q4 2023 adjusted EPS of $(0.10), missing the $(0.09) estimate, but sales of $62.21M exceeded the $60.55M forecast, marking a 25% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:34 pm

KVYO

Klaviyo (NYSE:KVYO) reported Q4 2023 earnings of $0.09 per share, surpassing the consensus estimate of $0.08. Sales reached $201.62M, exceeding the $196.15M estimate and marking a 38.82% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 9:33 pm